136 related articles for article (PubMed ID: 38380739)
1. EHMT2/G9a and EZH2: Epimarkers in testicular germ cell tumors.
Estevão-Pereira H; Guimarães-Teixeira C; Flores BCT; Moreira-Silva F; Tavares NT; Guimarães R; Braga I; Maurício J; Henrique R; Jerónimo C; Lobo J
Andrology; 2024 Feb; ():. PubMed ID: 38380739
[TBL] [Abstract][Full Text] [Related]
2. p53 and MDM2 expression in primary and metastatic testicular germ cell tumors: Association with clinical outcome.
Lobo J; Alzamora MA; Guimarães R; Cantante M; Lopes P; Braga I; Maurício J; Jerónimo C; Henrique R
Andrology; 2020 Sep; 8(5):1233-1242. PubMed ID: 32384200
[TBL] [Abstract][Full Text] [Related]
3. Dual EZH2 and G9a inhibition suppresses multiple myeloma cell proliferation by regulating the interferon signal and IRF4-MYC axis.
Ishiguro K; Kitajima H; Niinuma T; Maruyama R; Nishiyama N; Ohtani H; Sudo G; Toyota M; Sasaki H; Yamamoto E; Kai M; Nakase H; Suzuki H
Cell Death Discov; 2021 Jan; 7(1):7. PubMed ID: 33436557
[TBL] [Abstract][Full Text] [Related]
4. OCT4 staining in testicular tumors: a sensitive and specific marker for seminoma and embryonal carcinoma.
Jones TD; Ulbright TM; Eble JN; Baldridge LA; Cheng L
Am J Surg Pathol; 2004 Jul; 28(7):935-40. PubMed ID: 15223965
[TBL] [Abstract][Full Text] [Related]
5. Expression and prognostic significance of chromatin modulators EHMT2/G9a and KDM2b in acute myeloid leukemia.
Gouda MBY; Zidane MA; Abdelhady AS; Hassan NM
J Cell Biochem; 2022 Aug; 123(8):1340-1355. PubMed ID: 35696556
[TBL] [Abstract][Full Text] [Related]
6. D2-40 immunohistochemistry in the differential diagnosis of seminoma and embryonal carcinoma: a comparative immunohistochemical study with KIT (CD117) and CD30.
Lau SK; Weiss LM; Chu PG
Mod Pathol; 2007 Mar; 20(3):320-5. PubMed ID: 17277761
[TBL] [Abstract][Full Text] [Related]
7. Germ cell tumors of the gonads: a selective review emphasizing problems in differential diagnosis, newly appreciated, and controversial issues.
Ulbright TM
Mod Pathol; 2005 Feb; 18 Suppl 2():S61-79. PubMed ID: 15761467
[TBL] [Abstract][Full Text] [Related]
8. Testicular mixed germ cell tumors: a morphological and immunohistochemical study using stem cell markers, OCT3/4, SOX2 and GDF3, with emphasis on morphologically difficult-to-classify areas.
Gopalan A; Dhall D; Olgac S; Fine SW; Korkola JE; Houldsworth J; Chaganti RS; Bosl GJ; Reuter VE; Tickoo SK
Mod Pathol; 2009 Aug; 22(8):1066-74. PubMed ID: 19396148
[TBL] [Abstract][Full Text] [Related]
9. Deregulation of EZH2 expression in human spermatogenic disorders and testicular germ cell tumors.
Hinz S; Magheli A; Weikert S; Schulze W; Krause H; Schrader M; Miller K; Kempkensteffen C
World J Urol; 2010 Oct; 28(5):631-5. PubMed ID: 20043168
[TBL] [Abstract][Full Text] [Related]
10. G9a/EHMT2 is a Potential Prognostic Biomarker and Molecular Target in SHH Medulloblastoma.
Souza BK; Freire NH; Jaeger M; de Farias CB; Brunetto AL; Brunetto AT; Roesler R
Neuromolecular Med; 2022 Dec; 24(4):392-398. PubMed ID: 35113321
[TBL] [Abstract][Full Text] [Related]
11. Histone Methyltransferases G9a/
Souza BK; Freire NH; Monteiro TS; Herlinger AL; Jaeger M; Dalmolin MGS; de Farias CB; Gregianin L; Brunetto AT; Brunetto AL; Thiele CJ; Roesler R
Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37894922
[TBL] [Abstract][Full Text] [Related]
12. [Burned-out testicular germ cell tumors: a clinicopathological analysis of three cases].
Ni YP; Zhang ZH; Chen XY; Liu JS; Yang XQ
Zhonghua Bing Li Xue Za Zhi; 2023 Apr; 52(4):347-352. PubMed ID: 36973194
[No Abstract] [Full Text] [Related]
13. Association of intratubular seminoma and intratubular embryonal carcinoma with invasive testicular germ cell tumors.
Lau SK; Weiss LM; Chu PG
Am J Surg Pathol; 2007 Jul; 31(7):1045-9. PubMed ID: 17592271
[TBL] [Abstract][Full Text] [Related]
14. Wnt suppressor and stem cell regulator TCF7L1 is a sensitive immunohistochemical marker to differentiate testicular seminoma from non-seminomatous germ cell tumor.
Bu L; Yang Q; McMahon L; Xiao GQ; Li F
Exp Mol Pathol; 2019 Oct; 110():104293. PubMed ID: 31381875
[TBL] [Abstract][Full Text] [Related]
15. MAGEC2 is a sensitive and novel marker for seminoma: a tissue microarray analysis of 325 testicular germ cell tumors.
Bode PK; Barghorn A; Fritzsche FR; Riener MO; Kristiansen G; Knuth A; Moch H
Mod Pathol; 2011 Jun; 24(6):829-35. PubMed ID: 21780320
[TBL] [Abstract][Full Text] [Related]
16. Recently discovered EZH2 and EHMT2 (G9a) inhibitors.
Soumyanarayanan U; Dymock BW
Future Med Chem; 2016 Sep; 8(13):1635-54. PubMed ID: 27548656
[TBL] [Abstract][Full Text] [Related]
17. Prediction of relapse in stage I testicular germ cell tumor patients on surveillance: investigation of biomarkers.
Lobo J; Gillis AJM; van den Berg A; Looijenga LHJ
BMC Cancer; 2020 Aug; 20(1):728. PubMed ID: 32758242
[TBL] [Abstract][Full Text] [Related]
18. The lysine methyltransferase Ehmt2/G9a is dispensable for skeletal muscle development and regeneration.
Zhang RH; Judson RN; Liu DY; Kast J; Rossi FM
Skelet Muscle; 2016; 6():22. PubMed ID: 27239264
[TBL] [Abstract][Full Text] [Related]
19. Combined Inhibition of G9a and EZH2 Suppresses Tumor Growth via Synergistic Induction of IL24-Mediated Apoptosis.
Casciello F; Kelly GM; Ramarao-Milne P; Kamal N; Stewart TA; Mukhopadhyay P; Kazakoff SH; Miranda M; Kim D; Davis FM; Hayward NK; Vertino PM; Waddell N; Gannon F; Lee JS
Cancer Res; 2022 Apr; 82(7):1208-1221. PubMed ID: 35149587
[TBL] [Abstract][Full Text] [Related]
20. Clinical characteristics of testicular germ cell tumors in patients aged 50 years and older: A large-scale study from the Cancer Registration Committee of the Japanese Urological Association.
Kawai T; Tanaka Y;
Int J Urol; 2017 Feb; 24(2):124-128. PubMed ID: 27915468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
